High-Quality Pharmaceutical Grade Donepezil HCL - Top Choice for Alzheimer's Treatment
ProcurenetShort description
High-Quality Pharmaceutical Grade Donepezil HCL is a thoroughly produced active pharmaceutical ingredient (API) principally prescribed for Alzheimer’s treatment. It operates by driving Cholinesterase inhibition to magnify acetylcholine’s effect on cognition and memory impaired by Alzheimer’s. This API, noted for its CAS Number: 120011-70-3, ensures authenticity and traceability in the pharmaceutical trade. It is created in line with strict GMP standards, solidifying its superior quality. Make sure to ascertain the product’s grade and quality compliance with local regulations before incorporating it in any drug formulation.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
High-Quality Pharmaceutical Grade Donepezil HCL is a game-changing product in healthcare sectors, known predominantly for its usage in the treatment of Alzheimer's disease. Hailing directly from a top-tiered factory in China, this product stays top in the list as it assures unmatched efficacy and safety to the users.
- Compound Name: Donepezil Hydrochloride
- Synonyms: Aricept, Donepezilum, Donepezilo
- Molecular Formula: C24H29NO3.HCl
- Molecular Weight: 415.95 g/mol
- CAS Number: 120011-70-3
- IUPAC Name: 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one hydrochloride
- Canonical SMILES: OC1=C(C=C(C=C1OC)C(=O)C[C@H]2CCN(CC2)CC3=CC=CC=C3)OC.Cl
- Boiling Point: 581.5±50.0 °C at 760 mmHg
- Flash Point: 305.9±30.1 °C
- Mechanism of Action: Donepezil HCL functions as a cholinesterase inhibitor which bolsters the function of nerve cells in the brain, hence moderating mental decay.
- Pharmacological Class: This high-quality pharmaceutical grade Donepezil HCL falls under the Parasympathomimetic (Cholinergic) class of drugs.
- Therapeutic Uses: Donepezil HCL is an ideal choice for the treatment of confusion linked to Alzheimer's disease. Because of its high efficacy and safety profile, it has garnered a widespread demand in North America, Central/South America, Western Europe, Eastern Europe, and Asia.
- Dosage: Donepezil HCL is available in tablet forms of 5 mg and 10 mg. The initial recommended dose is 5mg/day, and it can be boosted to 10mg/day after a span of 4 to 6 weeks, based on the patient's response and tolerance.
- Side Effects: Common side effects are nausea, vomiting, and diarrhea. In most cases, these side effects are temporary and may decrease as the body adjusts to the medication. Always consult a healthcare provider for side effect concerns.
